Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
12 Out of 17 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod
How Is The Market Feeling About Biogen?
RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $72
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
Analysts Cite Improved Investor Sentiment For Gilead, But Warn of Limited Growth at Current Stock Levels